BA – Biology & Psychology, Boston University
MA – Biology, Boston University
MD – Jefferson Medical College, Thomas Jefferson University
Pediatric Internship/Residency – Children’s Hospital of Philadelphia
Pediatric Hematology/Oncology Fellowship – Johns Hopkins & National Institutes of Health Joint Fellowship
Bone Marrow Transplant Fellowship – St Jude Children’s Research Hospital
- Drug discovery and development of preclinical models
- Prevention and treatment of high-risk, relapsed and refractory disease
Goyama S, Schibler J, Cunningham L, Zhang Y, Rao Y, Nishimoto N, Nakagawa M, Olsson A, Wunderlich M, Link K, Mizukawa B, Grimes HL, Kurokawa M, Liu P, Huang G, Mulloy J. Prosurvival role for RUNX1 in acute myeloid leukemia. J Clin Invest 123(11):4979, 2013.
Cunningham L, Finckbeiner S, Southall N, Marugan J, Hyde R, Yedavalli V, Dehdashti S, Reinhold W, Alemu L, Yeh J, Sood R, Pommier Y, Austin C, Jeang K, Zheng W, Liu, P. Identification of Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. PNAS 109(36):14592-14597, 2012.
Mussai F, Cunningham L, Rezvani G, Stratakis C, Reynolds J, Nesterova G, Henshaw R, Levine J, Helman L, Arthur D, Kim S. Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndrome. J Pediatr Hematol Oncol 30(8):612-617, 2008.
Cunningham L, Aplenc R. Pharmacogenetics of acute lymphoblastic treatment response. Expert Opinion Pharmacotherapy 8(15):2519-2531, 2007.
Last update: July 2014